GLP-1 (Glucagon-Like Peptide-1) receptor agonistslike semaglutide or tirzepatideare injectable medications that assist in weight loss by regulating appetite, improving insulin sensitivity, and slowing gastric emptying
Medically reviewed by Lauren Okafor | MD , The Frank H Netter MD School of Medicine, Loyola University Medical Center on April 8th, 2026
Fat tissue, particularly around the abdomen, produces inflammatory proteins called cytokines
By activating both GIP and GLP-1 receptors, Mounjaro enhances insulin secretion in response to meals, suppresses glucagon release, slows gastric emptying, and reduces appetitemechanisms that collectively improve glycaemic control and promote weight loss
5a and c are representative of four different microscopy sessions
Dry Mouth (Xerostomia) One of the most common oral side effects reported with GLP-1 medications is dry mouth